Literature DB >> 30587522

Interactions with Muscle Cells Boost Fusion, Stemness, and Drug Resistance of Prostate Cancer Cells.

Berna Uygur1, Evgenia Leikina1, Kamran Melikov1, Rafael Villasmil2, Santosh K Verma1, Calvin P H Vary3, Leonid V Chernomordik4.   

Abstract

Poorly understood interactions with nonmalignant cells within the tumor microenvironment play an important role in cancer progression. Here, we explored interactions between prostate cancer and muscle cells that surround the prostate. We found that coculturing of prostate cancer cells with skeletal or smooth muscle cells expands the subpopulations of cancer cells with features characteristic of cancer stem-like cells, including anchorage-independent growth, elevated CD133 expression, and drug resistance. These changes in the properties of cancer cells depend on: (i) the muscle cell-induced increases in the concentrations of interleukins 4 and 13; (ii) the cytokine-induced upregulation of the expression of syncytin 1 and annexin A5; and (iii) cancer cell fusion. In human prostate cancer tissues, expression of syncytin 1 and annexin A5, proteins that we found to be required for the cell fusion, positively correlated with the cancer development suggesting that these proteins can be used as biomarkers to evaluate cancer progression and potential therapeutic targets. IMPLICATIONS: The discovered effects of muscle cells on prostate cancer cells reveal a novel and specific pathway by which muscle cells in the microenvironment of prostate cancer cells promote cell fusion and cancer progression. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2018        PMID: 30587522      PMCID: PMC8312562          DOI: 10.1158/1541-7786.MCR-18-0500

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  48 in total

Review 1.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

2.  Quantification of cell fusion events human breast cancer cells and breast epithelial cells using a Cre-LoxP-based double fluorescence reporter system.

Authors:  Marieke Mohr; Songül Tosun; Wolfgang H Arnold; Frank Edenhofer; Kurt S Zänker; Thomas Dittmar
Journal:  Cell Mol Life Sci       Date:  2015-04-22       Impact factor: 9.261

3.  Cell Fusion Connects Oncogenesis with Tumor Evolution.

Authors:  Xiaofeng Zhou; Kevin Merchak; Woojin Lee; Joseph P Grande; Marilia Cascalho; Jeffrey L Platt
Journal:  Am J Pathol       Date:  2015-06-08       Impact factor: 4.307

Review 4.  Tumour stem cells and drug resistance.

Authors:  Michael Dean; Tito Fojo; Susan Bates
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

5.  Involvement of human endogenous retroviral syncytin-1 in human osteoclast fusion.

Authors:  Kent Søe; Thomas L Andersen; Anne-Sofie Hobolt-Pedersen; Bolette Bjerregaard; Lars-Inge Larsson; Jean-Marie Delaissé
Journal:  Bone       Date:  2010-11-24       Impact factor: 4.398

Review 6.  Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis.

Authors:  John M Pawelek; Ashok K Chakraborty
Journal:  Nat Rev Cancer       Date:  2008-05       Impact factor: 60.716

7.  IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins.

Authors:  Concetta Conticello; Francesca Pedini; Ann Zeuner; Mariella Patti; Monica Zerilli; Giorgio Stassi; Angelo Messina; Cesare Peschle; Ruggero De Maria
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

8.  Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells.

Authors:  Dejuan Kong; Sanjeev Banerjee; Aamir Ahmad; Yiwei Li; Zhiwei Wang; Seema Sethi; Fazlul H Sarkar
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

Review 9.  Prostate cancer stroma: an important factor in cancer growth and progression.

Authors:  Božo Krušlin; Monika Ulamec; Davor Tomas
Journal:  Bosn J Basic Med Sci       Date:  2015-05-13       Impact factor: 3.363

10.  Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival.

Authors:  Charles E Gast; Alain D Silk; Luai Zarour; Lara Riegler; Joshua G Burkhart; Kyle T Gustafson; Michael S Parappilly; Minna Roh-Johnson; James R Goodman; Brennan Olson; Mark Schmidt; John R Swain; Paige S Davies; Vidya Shasthri; Shinji Iizuka; Patrick Flynn; Spencer Watson; James Korkola; Sara A Courtneidge; Jared M Fischer; Jerry Jaboin; Kevin G Billingsley; Charles D Lopez; Julja Burchard; Joe Gray; Lisa M Coussens; Brett C Sheppard; Melissa H Wong
Journal:  Sci Adv       Date:  2018-09-12       Impact factor: 14.136

View more
  9 in total

1.  Silencing YKL-40 gene can inhibit inflammatory factor expression and affects the effect of THP-1 cells on endometrial cancer.

Authors:  Qin Luo; Jiangtao Fan; Lili Li
Journal:  Arch Gynecol Obstet       Date:  2021-08-21       Impact factor: 2.344

2.  Involvement of the HERV-derived cell-fusion inhibitor, suppressyn, in the fusion defects characteristic of the trisomy 21 placenta.

Authors:  Jun Sugimoto; Danny J Schust; Tomomi Yamazaki; Yoshiki Kudo
Journal:  Sci Rep       Date:  2022-06-22       Impact factor: 4.996

Review 3.  Generation of Cancer Stem/Initiating Cells by Cell-Cell Fusion.

Authors:  Thomas Dittmar
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

4.  Linking unfolded protein response to ovarian cancer cell fusion.

Authors:  Lucile Yart; Daniel Bastida-Ruiz; Mathilde Allard; Pierre-Yves Dietrich; Patrick Petignat; Marie Cohen
Journal:  BMC Cancer       Date:  2022-06-07       Impact factor: 4.638

Review 5.  Cell fusion in cancer hallmarks: Current research status and future indications.

Authors:  Hao-Fei Wang; Wei Xiang; Bing-Zhou Xue; Yi-Hao Wang; Dong-Ye Yi; Xiao-Bing Jiang; Hong-Yang Zhao; Peng Fu
Journal:  Oncol Lett       Date:  2021-05-16       Impact factor: 2.967

Review 6.  How cells fuse.

Authors:  Nicolas G Brukman; Berna Uygur; Benjamin Podbilewicz; Leonid V Chernomordik
Journal:  J Cell Biol       Date:  2019-04-01       Impact factor: 10.539

Review 7.  Tumor Microenvironment in Prostate Cancer: Toward Identification of Novel Molecular Biomarkers for Diagnosis, Prognosis, and Therapy Development.

Authors:  Hisham F Bahmad; Mohammad Jalloul; Joseph Azar; Maya M Moubarak; Tamara Abdul Samad; Deborah Mukherji; Mohamed Al-Sayegh; Wassim Abou-Kheir
Journal:  Front Genet       Date:  2021-03-26       Impact factor: 4.599

Review 8.  Flagging fusion: Phosphatidylserine signaling in cell-cell fusion.

Authors:  Jarred M Whitlock; Leonid V Chernomordik
Journal:  J Biol Chem       Date:  2021-02-11       Impact factor: 5.157

Review 9.  Tumor Hybrid Cells: Nature and Biological Significance.

Authors:  Maria S Tretyakova; Ayalur R Subbalakshmi; Maxim E Menyailo; Mohit Kumar Jolly; Evgeny V Denisov
Journal:  Front Cell Dev Biol       Date:  2022-02-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.